Centers for Disease Control and Prevention. National Diabetes Statistics Report. https://www.cdc.gov/diabetes/data/statistics-report/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fdiabetes%2Fdata%2Fstatistics-report%2Fdiagnosed-undiagnosed-diabetes.html (Accessed January 03, 2024).

American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917-928. https://doi.org/10.2337/dci18-0007

Article  PubMed Central  Google Scholar 

Boyle, J.P., Thompson, T.J., Gregg, E.W., Barker, L.E. and Williamson, D.F., 2010. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population health metrics, 8, pp.1-12.

Article  Google Scholar 

Chamberlain, J.J., Rhinehart, A.S., Shaefer Jr, C.F. and Neuman, A., 2016. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Annals of internal medicine, 164(8), pp.542-552.

Article  PubMed  Google Scholar 

Asmat, K., Dhamani, K., Gul, R. and Froelicher, E.S., 2022. The effectiveness of patient-centered care vs. usual care in type 2 diabetes self-management: A systematic review and meta-analysis. Frontiers in public health, 10, p.994766.

American Diabetes Association; Standards of Medical Care in Diabetes—2013. Diabetes Care 1 January 2013; 36 (Supplement_1): S11–S66. https://doi.org/10.2337/dc13-S011

American Diabetes Association. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S7-S12. https://doi.org/10.2337/dc18-S001. PMID: 29222372.

American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38. https://doi.org/10.2337/dc22-S002. PMID: 34964875.

Konnyu, K. J., Yogasingam, S., Lépine, J., et al., 2023. Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes. The Cochrane database of systematic reviews, 5(5), CD014513. https://doi.org/10.1002/14651858.CD014513

Fazel, M.T., Bagalagel, A., Lee, J.K., Martin, J.R. and Slack, M.K., 2017. Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis. Annals of Pharmacotherapy, 51(10), pp.890-907.

Article  PubMed  Google Scholar 

Pousinho, S., Morgado, M., Falcão, A. and Alves, G., 2016. Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. Journal of managed care & specialty pharmacy, 22(5), pp.493-515.

Article  Google Scholar 

Aguiar, P.M., Brito, G.D.C., Lima, T.D.M., Santos, A.P.A.L., Lyra Jr, D.P. and Storpirtis, S., 2016. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 diabetic patients: a systematic review and meta-analysis. PLoS One, 11(3), p.e0150999.

Article  PubMed  PubMed Central  Google Scholar 

Chisholm-Burns, M.A., Lee, J.K., Spivey, C.A., et al., 2010. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Medical care, pp.923–933.

Callaway, B. and Sant’Anna, P.H., 2021. Difference-in-differences with multiple time periods. Journal of econometrics, 225(2), pp.200-230.

Article  Google Scholar 

Tahara, Y. and Shima, K., 1993. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes care, 16(9), pp.1313-1314.

Article  CAS  PubMed  Google Scholar 

Rohlfing, C.L., Wiedmeyer, H.M., Little, R.R., England, J.D., Tennill, A. and Goldstein, D.E., 2002. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes care, 25(2), pp.275-278.

Article  CAS  PubMed  Google Scholar 

Goldstein, D.E., Little, R.R., Lorenz, R.A., et al., 2004. Tests of glycemia in diabetes. Diabetes care, 27(7), pp.1761-1773.

Article  PubMed  Google Scholar 

Elixhauser, A., Steiner, C., Harris, D.R. and Coffey, R.M., 1998. Comorbidity measures for use with administrative data. Medical care, pp.8–27.

Jaber, L.A., Halapy, H., Fernet, M., Tummalapalli, S. and Diwakaran, H., 1996. Evaluation of a pharmaceutical care model on diabetes management. Annals of Pharmacotherapy, 30(3), pp.238-243.

Article  CAS  PubMed  Google Scholar 

Hetro, A., Rossetto, J., Bahlawan, N. and Ryan, M., 2015. Clinical pharmacists supporting patients with diabetes and/or hyperlipidemia in a military medical home. Journal of the American Pharmacists Association, 55(1), pp.73-76.

Article  PubMed  Google Scholar 

Goodman-Bacon, A., 2021. Difference-in-differences with variation in treatment timing. Journal of Econometrics, 225(2), pp.254-277.

Article  Google Scholar 

Sun, L. and Abraham, S., 2021. Estimating dynamic treatment effects in event studies with heterogeneous treatment effects. Journal of Econometrics, 225(2), pp.175-199.

Article  Google Scholar 

Ashenfelter, O., 1978. Estimating the effect of training programs on earnings. The Review of Economics and Statistics, pp.47–57.

Card, D., Ibarrarán, P. and Villa, J.M., 2011. Building in an evaluation component for active labor market programs: A practitioner's guide.